Healthcare provider profile · identity verified

Brianne Addicks, ANP

Nurse Practitioner · BRENHAM, TX · NPI 1790983062

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	271	94
Amlodipine Besylate	Amlodipine Besylate	175	67
Levothyroxine Sodium	Levothyroxine Sodium	143	45
Rosuvastatin Calcium	Rosuvastatin Calcium	114	47
Fluticasone Propionate	Fluticasone Propionate	113	61
Metformin Hcl	Metformin Hcl	97	34
Losartan Potassium	Losartan Potassium	95	34
Omeprazole	Omeprazole	94	42
Sertraline Hcl	Sertraline Hcl	90	31
Lisinopril	Lisinopril	87	33
Metoprolol Succinate	Metoprolol Succinate	87	31
Alendronate Sodium	Alendronate Sodium	79	31
Pantoprazole Sodium	Pantoprazole Sodium	76	26
Ozempic	Semaglutide	73	18
Famotidine	Famotidine	69	31
Albuterol Sulfate Hfa	Albuterol Sulfate	68	45
Prednisone	Prednisone	66	34
Meloxicam	Meloxicam	57	27
Tamsulosin Hcl	Tamsulosin Hcl	57	23
Tramadol Hcl	Tramadol Hcl	57	24
Trazodone Hcl	Trazodone Hcl	56	19
Gabapentin	Gabapentin	54	20
Metformin Hcl Er	Metformin Hcl	54	23
Montelukast Sodium	Montelukast Sodium	51	17
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	48	16
Hydrochlorothiazide	Hydrochlorothiazide	43	19
Tizanidine Hcl	Tizanidine Hcl	42	13
Vitamin D2	Ergocalciferol (Vitamin D2)	42	21
Simvastatin	Simvastatin	40	15
Allopurinol	Allopurinol	39	14
Pravastatin Sodium	Pravastatin Sodium	39	14
Carvedilol	Carvedilol	38	12
Azithromycin	Azithromycin	37	34
Trulicity	Dulaglutide	37	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	36	13
Jardiance	Empagliflozin	34	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	33	12
Venlafaxine Hcl Er	Venlafaxine Hcl	33	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	30	suppressed
Buspirone Hcl	Buspirone Hcl	29	13
Valsartan	Valsartan	28	14
Oxybutynin Chloride Er	Oxybutynin Chloride	27	12
Cefdinir	Cefdinir	26	25
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	26	14
Furosemide	Furosemide	26	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	25	12
Farxiga	Dapagliflozin Propanediol	25	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	25	11
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	25	13
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	22	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	22	18
Bupropion Xl	Bupropion Hcl	22	suppressed
Glipizide Er	Glipizide	22	suppressed
Atenolol	Atenolol	21	suppressed
Fenofibrate	Fenofibrate	21	suppressed
Hydralazine Hcl	Hydralazine Hcl	21	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	20	suppressed
Pregabalin	Pregabalin	19	suppressed
Synthroid	Levothyroxine Sodium	19	suppressed
Alprazolam	Alprazolam	18	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	18	11
Duloxetine Hcl	Duloxetine Hcl	18	suppressed
Glimepiride	Glimepiride	18	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	18	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	18	suppressed
Clopidogrel	Clopidogrel Bisulfate	17	suppressed
Ezetimibe	Ezetimibe	16	suppressed
Paroxetine Hcl	Paroxetine Hcl	16	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	14	13
Citalopram Hbr	Citalopram Hydrobromide	14	suppressed
Valacyclovir	Valacyclovir Hcl	14	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	14	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	13	suppressed
Clonidine Hcl	Clonidine Hcl	13	suppressed
Fluconazole	Fluconazole	13	suppressed
Nystatin	Nystatin	13	suppressed
Telmisartan	Telmisartan	13	suppressed
Nateglinide	Nateglinide	12	suppressed
Nifedipine Er	Nifedipine	12	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	12	11
Celecoxib	Celecoxib	11	suppressed
Finasteride	Finasteride	11	suppressed
Memantine Hcl	Memantine Hcl	11	suppressed
Mirtazapine	Mirtazapine	11	suppressed
Ondansetron Hcl	Ondansetron Hcl	11	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	11	suppressed
Potassium Chloride	Potassium Chloride	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error